EMBL Australian Partner Laboratory Group Leader

Canberra, Australia
15 Jul 2017
End of advertisement period
13 Aug 2017
Contract Type
Fixed Term
Full Time

Expressions of interest are invited from suitably qualified scientists wishing to develop their scientific research career as an EMBL Australia Partner Laboratory Group Leader hosted at the Australian Cancer Research Foundation (ACRF) Department of Cancer Biology and Therapeutics at The John Curtin School of Medical Research (JCSMR), The Australian National University (ANU), Canberra, Australia.


  • Excellent, nurturing scientific environment;
  • State-of-the-art laboratories and access to leading-edge core research facilities;
  • Provision of core research funding and support;
  • Competitive terms and conditions, including relocation, removal and travel benefits. Salary packaging is also available for certain items;
  • A range of professional development programs, support for research, study and overseas work; and
  • ANU offers generous parental leave and flexible working arrangements. It is also an inaugural member of the Science in Australia Gender Equity (SAGE) Pilot Program that aims to address gender equity in Science, Technology, Engineering, Mathematics and Medicine (STEMM).


  • Applicants will be expected to have an exceptional international research profile in cancer biology, an excellent publication output, including recent discoveries published in high-profile scientific journals and a highly successful record of obtaining competitive funding.
  • If you have the qualifications and high-level experience required to lead a new team of researchers in the genetic and epigenetic regulation of gene expression in cancer, we welcome your application.
  • The ANU is highly supportive of, and encourages, applications from females and minority groups.

EMBL Australia Partner Laboratory Network: Australia is the first associate member of the European Molecular Biology Laboratory (EMBL). EMBL is an intergovernmental research organisation that fosters excellence by providing a highly collaborative environment that benefits the research of all its scientists, whether at graduate, post-doctoral or group leader level. A key initiative of the associate membership is the EMBL Australia Partner Laboratory Network, a partnership of Australian research institutions, which - following the EMBL’s operational model - provide long-term funded research-only positions allowing early to mid-career researchers to pursue ambitious research programs. The ANU recently established a new node of the Partner Laboratory Network within The John Curtin School of Medical Research. For more information about EMBL Australia Partner Laboratory Network, visit www.emblaustralia.org.

The Department:

The newly formed ACRF Department of Cancer Biology and Therapeutics is led by Professor Ross Hannan. The Department uses the latest “omics” technologies combined with classic biochemistry, cell biology, immunology and clinically relevant transgenic and patient-derived xenograph models of cancer to provide new knowledge of the fundamental mechanisms driving malignant transformation and metastasis. Through strategic alliances with industry and pharmaceutical companies, we are translating these findings into new therapeutics for the treatment of cancer. Work undertaken in our laboratories has led to novel drugs in Phase I, II and III trials for the treatment of both solid and hematologic malignancies.

The Position:

A major focus of the ACRF Department of Cancer Biology and Therapeutics is a collaboration with the Department of Genome Sciences at the JCSMR to establish an internationally competitive program of research focused on understanding the fundamental mechanisms controlling gene expression. Our interests stretch from understanding core transcription apparatus and chromatin modifiers, the role of ncRNA in regulating transcriptional process and finally the mechanisms orchestrating mRNA translation. In order to capitalise on these strengths and to further enhance our critical mass and collaborative research, we are seeking to recruit an EMBL Australia Partner Laboratory Group Leader with internationally competitive research expertise in the genetic and epigenetic regulation of gene expression in cancer.

The position, to be hosted at the ACRF Department of Cancer Biology and Therapeutics, provides research-intensive employment as an independent laboratory head. The position provides the opportunity to foster excellence and deliver leadership in a range of medical research projects, to supervise students, and to undertake professional activities and policy development in an academic discipline within the School, the University, and the wider community.

The successful applicant will lead a research group for a period of five years, with the possibility of extension for an additional four years. The successful applicant will participate in the collegial, collaborative culture of the EMBL Australia Partner Laboratory Network. The candidate will actively support the development of the network by participating in the various programs aimed to internationalise research conducted in Australia via linking activities with EMBL in Europe.

Duration:  The appointment will be for a period of five years with the possibility of extension for an additional four years.

Level: Appointment will be made at the relevant level, subject to the skills and experience of the successful candidate. The salary will be at ANU Academic Level C or D ($133,296 - $170,322 inclusive of 17% superannuation contributions) plus EMBL Australia loading.

Commencement Date: The start date will be negotiated with the successful applicant.

Closing Date for Applications: Applications are to be submitted by midnight on 13th August 2017 (AEST - Canberra, Australia). Interviews will be held in Canberra in the week commencing 28th November 2017.

Position Description: PD for Cancer Level CD 10July17_Final.docx

To express your interest, please submit the following documents in English:

A cover letter, CV, and a summary of present and future research interests, via the University’s job vacancies website, Ref No. 517024.

Further information about this role can be obtained from jcsmr.director@anu.edu.au

The Australian National University provides attractive benefits and excellent support to maintain a healthy work/life balance and offers generous remuneration benefits, including four weeks paid vacation per year, assistance with relocation expenses and 17% employer contribution to superannuation. This also includes generous parental leave, the possibility of flexible and part time working arrangements, a parental and aged care support program, dual career hire programs, ANU school holiday programs, and childcare facilities on campus. For more information, please visit http://hr.anu.edu.au/employment-at-anu and http://jcsmr.anu.edu.au/research/departments/acrf-department-cancer-biology-and-therapeutics

ANU values diversity and inclusion and believes employment opportunities must not be limited by socio-economic background, race, religion or gender. The University actively encourages applications from women, Aboriginal and Torres Strait Islander people and candidates from culturally and linguistically diverse backgrounds.  For more information about staff equity at ANU, visit http://hr.anu.edu.au/staff-equity or contact our Indigenous Employment Consultant via indigenous.employment@anu.edu.au.